Combination therapy using angiogenesis inhibitors and anticancer drugs can improve drug delivery into tumour tissues and prolong progression-free survival. (Source: File Photo) Combination therapy using angiogenesis inhibitors and anticancer drugs can improve drug delivery into tumour tissues and prolong progression-free survival. Combination therapy using angiogenesis inhibitors and anticancer drugs can improve drug delivery into tumour tissues and prolong progression-free survival. “Vascular normalisation by angiogenesis inhibitors, such as vascular endothelial growth factor (VEGF) signalling inhibitors, is a promising method for improvement of chemotherapy. “However, it is unclear how we can recognise the ‘window of opportunity’ for a tumour vascular normalising period for the effective timing of anti-cancer drug treatment.

Source: Indian Express April 09, 2018 09:00 UTC